NCT04038853View on ClinicalTrials.gov

Vitamin D in Fatty Liver Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

December 1, 2015

Primary Completion Date

February 1, 2017

Study Completion Date

April 1, 2019

Conditions
Non-alcoholic Fatty Liver DiseaseVitamin D Deficiency
Interventions
DRUG

1,25-Dihydroxyvitamin D

1,25-dihydroxy-vitamin D3 1000 IU orally daily for 12 months

DRUG

Placebo

Placebo identical to the study intervention drug

All Listed Sponsors
collaborator

University of Rijeka

OTHER

collaborator

Pliva Hrvatska d.o.o.

UNKNOWN

lead

University Hospital Rijeka

OTHER

NCT04038853 - Vitamin D in Fatty Liver Disease | Biotech Hunter | Biotech Hunter